MedPath

PROMETHEGAN

PROMETHAZINE HYDROCHLORIDE SUPPOSITORIES, USP Rx Only

Approved
Approval ID

636bb9bc-0cc5-4d6a-85be-6471acf01ffc

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 30, 2023

Manufacturers
FDA

Cosette Pharmaceuticals, Inc.

DUNS: 116918230

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

promethazine hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0713-0132
Application NumberANDA087165
Product Classification
M
Marketing Category
C73584
G
Generic Name
promethazine hydrochloride
Product Specifications
Route of AdministrationRECTAL
Effective DateNovember 30, 2023
FDA Product Classification

INGREDIENTS (4)

ASCORBYL PALMITATEInactive
Code: QN83US2B0N
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
HARD FATInactive
Code: 8334LX7S21
Classification: IACT
PROMETHAZINE HYDROCHLORIDEActive
Quantity: 50 mg in 1 1
Code: R61ZEH7I1I
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PROMETHEGAN - FDA Drug Approval Details